Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
about
Watch and wait approach to rectal cancer: A reviewNeoadjuvant treatment for rectal cancer-A value-based proposition.Multidisciplinary treatment of rectal cancer in 2014: where are we going?Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancerGood and complete responding locally advanced rectal tumors after chemoradiotherapy: where are the residual positive nodes located on restaging MRI?Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysisLong-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic ResponseCurrent issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyInfluence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer.A scoring system basing pathological parameters to predict regional lymph node metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer: implication for local excision.Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?Pitfalls of transanal endoscopic microsurgery for rectal cancer following neoadjuvant chemoradiation therapy.Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.Surgery for colorectal polyps: histological features, current indications, critical points, future perspective and ongoing studies.Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.KRAS mutations and rectal cancer response to chemoradiation: are we closer to personalization of therapy?Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.Local Excision and Endoscopic Resections for Early Rectal Cancer.Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?[Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection.
P2860
Q28080688-9F5684C1-54F6-4BAA-90F1-62E063D298CCQ30251516-3EBE6FEF-5CC8-4B4B-A466-11A0A3BF99FAQ34093825-5AFC1F6F-7AB4-43C5-AE0D-7B47EEA8B8CEQ35793914-BF870C8E-2A9E-4D79-88A2-9D149AD1BC54Q36091170-7AAA84A0-3A0F-41D8-AB16-0D7B4304714BQ37017653-302DCA6A-A5AB-4C87-9F52-8533B70B4E3FQ37231196-72856714-9E68-4C6F-9685-AE79B9C08E6DQ37385667-1C37D5EE-9B12-4EAB-8768-E5AB78C4C82AQ37602735-D10196AB-992F-4B5D-999A-19E640769B45Q37624231-8F52B7A3-0FF0-4468-851B-7881EA69AC88Q37694658-65256AA6-30DD-4A92-B9AC-122A6FF3929DQ37705840-4310DE00-C144-4463-9F46-8C9AA72D00ABQ38196468-482FA728-51E5-4B68-993A-73C1C9F3C102Q38264771-DA35ED27-7BFD-4786-930A-753010829E9FQ39076006-90862348-D413-4A62-936E-CCF7FF004B2BQ41162013-881F7AFB-6E34-4197-9497-FCF0B2A7C5DCQ45175220-F3CD87DF-49E3-4589-8BBD-8804727E9E77Q47988485-0B247AFD-75F9-4CCC-97DB-34124C1DC12AQ49564044-F1ADB8B7-F9D0-44B0-BF07-F48AE860A281Q49564138-649C6B4F-90AA-4CCE-99C8-A085865F60D6Q50631955-D25D2990-4378-4F6F-8741-CB7D8554D896Q50936327-F9A5952E-F0AB-453B-9ED6-B4F28DB76DECQ53116748-F3A29D14-083A-4ADC-8A4D-065A1E6FDFA6Q53154643-18CF0CF0-E350-4400-973F-0ADC3A76C3BBQ53742592-A5AF73C2-286A-4909-BCCA-60B25A77D5F9Q55401858-831F0511-1F56-421F-9228-02D66136EBCD
P2860
Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@ast
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@en
type
label
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@ast
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@en
prefLabel
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@ast
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy.
@en
P2093
P2860
P1476
Comparative analysis of lymph ...... neoadjuvant chemoradiotherapy
@en
P2093
Barry Feig
Chung-Yuan Hu
George J Chang
John M Skibber
Miguel A Rodriguez-Bigas
Y Nancy You
P2860
P304
P356
10.1097/DCR.0B013E318278FF8A
P50
P577
2013-02-01T00:00:00Z